original_query: What is the purpose of the ULTRA-DD program?
query: What is the purpose of the ULTRA-DD program?
answer: The ULTRA-DD program, funded by the European Commission's Innovative Medicines Initiative (IMI), aims to identify and validate under-explored targets in autoimmune and inflammatory disease models.  Patient-derived cell lines are screened against chemical modulators to obtain phenotypic read-outs in a disease-relevant context.